ITRM logo

Iterum Therapeutics (ITRM) Shareholders Equity

Annual Shareholders Equity

-$6.40 M
-$34.40 M-122.87%

December 31, 2023


Summary


Performance

ITRM Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITRMbalance sheetmetrics:

Quarterly Shareholders Equity

-$11.51 M
-$594.00 K-5.44%

September 30, 2024


Summary


Performance

ITRM Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITRMbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ITRM Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-122.9%0.0%
3 y3 years+87.3%0.0%
5 y5 years-108.9%0.0%

ITRM Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-112.8%at low-122.9%at low
5 y5-year-112.8%+87.3%-121.9%+79.4%
alltimeall time-108.9%+87.3%-109.7%+79.4%

Iterum Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
-$11.51 M(+5.4%)
Jun 2024
-
-$10.91 M(+77.4%)
Mar 2024
-
-$6.15 M(-4.0%)
Dec 2023
-$6.40 M(-122.9%)
-$6.40 M(-286.6%)
Sep 2023
-
$3.43 M(-51.9%)
Jun 2023
-
$7.13 M(-62.4%)
Mar 2023
-
$18.96 M(-32.3%)
Dec 2022
$28.00 M(-44.3%)
$28.00 M(-14.0%)
Sep 2022
-
$32.55 M(-25.8%)
Jun 2022
-
$43.89 M(-9.8%)
Mar 2022
-
$48.63 M(-3.2%)
Dec 2021
$50.23 M
$50.23 M(-4.2%)
Sep 2021
-
$52.45 M(+11.1%)
Jun 2021
-
$47.20 M(+49.7%)
DateAnnualQuarterly
Mar 2021
-
$31.52 M(-162.3%)
Dec 2020
-$50.56 M(+92.7%)
-$50.56 M(-9.6%)
Sep 2020
-
-$55.90 M(+14.6%)
Jun 2020
-
-$48.79 M(+16.9%)
Mar 2020
-
-$41.74 M(+59.1%)
Dec 2019
-$26.24 M(-136.6%)
-$26.24 M(+747.5%)
Sep 2019
-
-$3.10 M(-112.6%)
Jun 2019
-
$24.58 M(-52.4%)
Mar 2019
-
$51.63 M(-27.9%)
Dec 2018
$71.62 M(+81.3%)
$71.62 M(-23.9%)
Sep 2018
-
$94.10 M(-20.6%)
Jun 2018
-
$118.53 M(+98.4%)
Mar 2018
-
$59.73 M(+51.2%)
Dec 2017
$39.49 M(+74.2%)
$39.49 M
Dec 2016
$22.67 M
-

FAQ

  • What is Iterum Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Iterum Therapeutics?
  • What is Iterum Therapeutics annual shareholders equity year-on-year change?
  • What is Iterum Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Iterum Therapeutics?
  • What is Iterum Therapeutics quarterly shareholders equity year-on-year change?

What is Iterum Therapeutics annual stockholders equity?

The current annual shareholders equity of ITRM is -$6.40 M

What is the all time high annual shareholders equity for Iterum Therapeutics?

Iterum Therapeutics all-time high annual stockholders equity is $71.62 M

What is Iterum Therapeutics annual shareholders equity year-on-year change?

Over the past year, ITRM annual stockholders equity has changed by -$34.40 M (-122.87%)

What is Iterum Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of ITRM is -$11.51 M

What is the all time high quarterly shareholders equity for Iterum Therapeutics?

Iterum Therapeutics all-time high quarterly stockholders equity is $118.53 M

What is Iterum Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, ITRM quarterly stockholders equity has changed by $0.00 (0.00%)